<div id="readability-page-1"><p><span>Rocket Lab (NASDAQ:RKLB - Get Free Report)</span> had its price target dropped by equities research analysts at Morgan Stanley  from $68.00 to $67.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an &#34;equal weight&#34; rating on the rocket manufacturer's stock. Morgan Stanley's target price would suggest a potential upside of 32.42% from the stock's previous close.</p><ul><li>Rocket Lab Stock Jumps After Earnings, Despite Neutron Delay</li></ul><p>A number of other brokerages have also commented on RKLB. Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of Rocket Lab in a research report on Wednesday, October 8th. Stifel Nicolaus  reissued a &#34;buy&#34; rating and issued a $75.00 price target (up from $65.00) on shares of Rocket Lab in a research note on Tuesday. Bank of America increased their price target on shares of Rocket Lab from $30.00 to $50.00 and gave the stock a &#34;buy&#34; rating in a research note on Wednesday, July 16th. Roth Capital  reaffirmed a &#34;buy&#34; rating and issued a $75.00 price objective on shares of Rocket Lab in a research note on Tuesday. Finally, Robert W. Baird initiated coverage on Rocket Lab in a research report on Wednesday, October 15th. They set an &#34;outperform&#34; rating and a $83.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued  a Hold rating and one  has issued  a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $57.33.</p><p><b>Get Our Latest Report on RKLB</b></p><h2>Rocket Lab Price Performance</h2><ul><li>MarketBeat Week in Review – 10/27 - 10/31</li></ul><p>Shares of RKLB traded down $0.64 during trading hours on Wednesday, reaching $50.60. The company had a trading volume of 13,967,462 shares, compared to its average volume of 20,764,912. The company has a market capitalization of $24.49 billion, a price-to-earnings ratio of -132.85 and a beta of 2.16. Rocket Lab has a 12-month low of $14.71 and a 12-month high of $73.97. The firm has a 50 day simple moving average of $55.74 and a 200-day simple moving average of $42.52. The company has a current ratio of 2.67, a quick ratio of 2.33 and a debt-to-equity ratio of 0.60. </p><p>Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its earnings results on Monday, November 10th. The rocket manufacturer reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. The business had revenue of $155.08 million during the quarter, compared to the consensus estimate of $152.45 million. Rocket Lab had a negative net margin of 35.64% and a negative return on equity of 37.88%. The business's quarterly revenue was up 48.0% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.10) earnings per share.  Rocket Lab has set its Q4 2025 guidance at  EPS. Research analysts expect that  Rocket Lab will post -0.38 earnings per share for the current year. </p><h2>Insider Activity at Rocket Lab</h2><ul><li>Rocket Lab Stock Dips 14%—Buying Opportunity Ahead?</li></ul><p>In related news, CFO Adam C. Spice sold 874,588 shares of the business's stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $48.01, for a total value of $41,988,969.88. Following the completion of the transaction, the chief financial officer owned 2,057,889 shares of the company's stock, valued at $98,799,250.89. The trade was a 29.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, SVP Arjun Kampani sold 31,185 shares of Rocket Lab stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $48.97, for a total transaction of $1,527,129.45. Following the transaction, the senior vice president owned 499,045 shares of the company's stock, valued at $24,438,233.65. This represents a 5.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 5,406,361 shares of company stock worth $267,483,973 over the last ninety days. Company insiders own  11.90% of the company's stock. </p><h2>Hedge Funds Weigh In On Rocket Lab</h2><p>Hedge funds have recently bought and sold shares of the business. Baillie Gifford &amp; Co. increased its holdings in shares of  Rocket Lab by 176.1% in the 3rd quarter. Baillie Gifford &amp; Co. now owns 12,125,910 shares of the rocket manufacturer's stock worth $580,952,000 after buying an additional 7,734,788 shares during the last quarter.  Kingstone Capital Partners Texas LLC acquired a new stake in shares of  Rocket Lab during the second quarter worth $192,918,000.  Norges Bank purchased a new stake in shares of  Rocket Lab during the second quarter valued at $164,751,000.  Vanguard Group Inc. increased its position in shares of  Rocket Lab by 10.6% in the 1st quarter. Vanguard Group Inc. now owns 40,029,546 shares of the rocket manufacturer's stock valued at $715,728,000 after acquiring an additional 3,833,969 shares during the period.  Finally, Invesco Ltd. lifted its holdings in shares of  Rocket Lab by 67.0% during the second quarter. Invesco Ltd. now owns 6,242,304 shares of the rocket manufacturer's stock worth $223,287,000 after purchasing an additional 2,504,054 shares during the period. Hedge funds and other institutional investors own  71.78% of the company's stock. </p><h2>Rocket Lab Company Profile</h2> (Get Free Report)<p>Rocket Lab USA, Inc, a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Rocket Lab</li><li>What is Put Option Volume?</li><li>Is Qualcomm Up 40% or Down 20%? 2 Contrarian Takes</li><li>Consumer Discretionary Stocks Explained</li><li>Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast</li><li>Mastering Discipline: Overcoming Emotional Challenges In Trading</li><li>Rocket Lab Stock Jumps After Earnings, Despite Neutron Delay</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UktMQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UktMQg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Rocket Lab Right Now?</h2><p>Before you consider Rocket Lab, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.</p><p>While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

RKLB

<p>Morgan Stanley has lowered its price target for Rocket Lab (NASDAQ:RKLB) from $68.00 to $67.00, maintaining an "equal weight" rating. This suggests a potential upside of 32.42% from the stock's previous close. Other brokerages have varied opinions, with Weiss Ratings issuing a "sell" rating, while Stifel Nicolaus and Bank of America have set higher targets of $75.00 and $50.00, respectively. Rocket Lab's stock has seen fluctuations, trading down to $50.60 recently, with a market cap of $24.49 billion and a negative net margin of 35.64%.</p>

Morgan Stanley Lowers Rocket Lab (NASDAQ:RKLB) Price Target to $67.00